Tempus AI, Inc. $TEM Stock: International Assets Investment Management LLC Increases Holdings

International Assets Investment Management LLC lifted its stake in shares of Tempus AI, Inc. (NASDAQ:TEM) by 3,027.6% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 104,555 shares of the company’s stock after purchasing an additional 101,212 shares during the quarter. International Assets Investment Management LLC’s holdings in Tempus AI were worth $8,563,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Guardian Partners Inc. boosted its holdings in shares of Tempus AI by 8.3% during the 3rd quarter. Guardian Partners Inc. now owns 2,600 shares of the company’s stock valued at $213,000 after acquiring an additional 200 shares in the last quarter. V Square Quantitative Management LLC bought a new stake in Tempus AI during the 3rd quarter worth $27,000. Cyndeo Wealth Partners LLC grew its position in Tempus AI by 6.7% during the 3rd quarter. Cyndeo Wealth Partners LLC now owns 6,412 shares of the company’s stock worth $525,000 after acquiring an additional 400 shares during the last quarter. Arkadios Wealth Advisors grew its position in Tempus AI by 9.6% during the 1st quarter. Arkadios Wealth Advisors now owns 4,963 shares of the company’s stock worth $224,000 after acquiring an additional 435 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in Tempus AI by 54.3% in the 3rd quarter. GAMMA Investing LLC now owns 1,239 shares of the company’s stock worth $101,000 after purchasing an additional 436 shares in the last quarter. 24.22% of the stock is currently owned by institutional investors.

Insider Transactions at Tempus AI

In other news, CEO Eric P. Lefkofsky sold 250,000 shares of the stock in a transaction dated Tuesday, October 27th. The stock was sold at an average price of $70.36, for a total value of $17,590,000.00. Following the completion of the sale, the chief executive officer owned 50,000 shares of the company’s stock, valued at approximately $3,518,000. This represents a 83.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Andrew Polovin sold 2,951 shares of the firm’s stock in a transaction dated Thursday, September 17th. The stock was sold at an average price of $75.00, for a total value of $221,325.00. Following the transaction, the executive vice president owned 135,189 shares of the company’s stock, valued at $10,139,175. This trade represents a 2.14% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 1,280,965 shares of company stock worth $87,472,564. 24.26% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities analysts have commented on TEM shares. Canaccord Genuity Group increased their target price on Tempus AI from $80.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, October 12th. TD Cowen reissued a “buy” rating on shares of Tempus AI in a research note on Wednesday, July 15th. Guggenheim boosted their price target on Tempus AI from $65.00 to $92.00 and gave the stock a “buy” rating in a report on Thursday, October 1st. Piper Sandler raised Tempus AI from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $56.00 to $76.00 in a research note on Tuesday, September 1st. Finally, The Goldman Sachs Group started coverage on Tempus AI in a research note on Monday, September 21st. They issued a “neutral” rating and a $75.00 price objective for the company. Eleven research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $72.47.

Tempus AI Stock Performance

NASDAQ TEM opened at $72.22 on Friday. The company has a market capitalization of $13.03 billion, a price-to-earnings ratio of -50.15 and a beta of 3.54. Tempus AI, Inc. has a twelve month low of $40.77 and a twelve month high of $90.53. The stock has a fifty day simple moving average of $70.69 and a 200 day simple moving average of $57.07. The company has a quick ratio of 3.16, a current ratio of 3.30 and a debt-to-equity ratio of 3.06.

Tempus AI (NASDAQ:TEM) last announced its earnings results on Thursday, July 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.10. The business had revenue of $382.49 million during the quarter, compared to analyst estimates of $379.69 million. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%. Tempus AI’s revenue for the quarter was up 21.6% compared to the same quarter last year. During the same period last year, the company earned ($0.22) EPS. Sell-side analysts expect that Tempus AI, Inc. will post -1.45 EPS for the current year.

About Tempus AI

Tempus AI, Inc is a healthcare technology company that uses artificial intelligence and data analytics to support precision medicine. The company combines clinical, molecular and imaging data to help physicians make more informed treatment decisions and to help researchers and biopharmaceutical companies develop therapies.

Its offerings include genomic testing and analysis, such as tissue- and blood-based tests, as well as software tools designed to assist with clinical decision-making, patient matching for clinical trials and the management of healthcare data.